Literature DB >> 18670638

Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesis.

Massimiliano Mellone1, Christian Rinaldi, Isabella Massimi, Marialaura Petroni, Veronica Veschi, Claudio Talora, Silvia Truffa, Helena Stabile, Luigi Frati, Isabella Screpanti, Alberto Gulino, Giuseppe Giannini.   

Abstract

HMGA1 is a member of a small family of architectural transcription factors involved in the coordinate assembly of multiprotein complexes referred to as enhanceosomes. In addition to their role in cell proliferation, differentiation, and development, high-mobility group proteins of the A type (HMGA) family members behave as transforming protoncogenes either in vitro or in animal models. Recent reports indicated that HMGA1 might counteract p53 pathway and provided an interesting hint on the mechanisms determining HMGA's transforming potential. HMGA1 expression is deregulated in a very large array of human tumors, including cervical cancer, but very limited information is available on the molecular mechanisms leading to HMGA1 deregulation in cancer cells. Here, we report that HMGA1 expression is sustained by human papilloma virus (HPV) E6/E7 proteins in cervical cancer, as demonstrated by either E6/E7 overexpression or by repression through RNA interference. Knocking down HMGA1 expression by means of RNA interference, we also showed that it is involved in cell proliferation and contributes to p53 inactivation in this type of neoplasia. Finally, we show that HMGA1 is necessary for the full expression of HPV18 E6 and E7 oncoproteins thus establishing a positive autoregulatory loop between HPV E6/E7 and HMGA1 expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18670638      PMCID: PMC2481567          DOI: 10.1593/neo.08462

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  57 in total

1.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

2.  Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome.

Authors:  N Munshi; M Merika; J Yie; K Senger; G Chen; D Thanos
Journal:  Mol Cell       Date:  1998-10       Impact factor: 17.970

3.  Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix.

Authors:  A Bandiera; D Bonifacio; G Manfioletti; F Mantovani; A Rustighi; F Zanconati; A Fusco; L Di Bonito; V Giancotti
Journal:  Cancer Res       Date:  1998-02-01       Impact factor: 12.701

4.  Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins.

Authors:  M Fedele; A Bandiera; G Chiappetta; S Battista; G Viglietto; G Manfioletti; A Casamassimi; M Santoro; V Giancotti; A Fusco
Journal:  Cancer Res       Date:  1996-04-15       Impact factor: 12.701

5.  Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker.

Authors:  N Abe; T Watanabe; M Sugiyama; H Uchimura; G Chiappetta; A Fusco; Y Atomi
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

6.  HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.

Authors:  G Giannini; L Di Marcotullio; E Ristori; M Zani; M Crescenzi; S Scarpa; G Piaggio; A Vacca; F A Peverali; F Diana; I Screpanti; L Frati; A Gulino
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

7.  HMG-I/Y, a new c-Myc target gene and potential oncogene.

Authors:  L J Wood; M Mukherjee; C E Dolde; Y Xu; J F Maher; T E Bunton; J B Williams; L M Resar
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  Human papillomavirus type 16 E6 protein up-regulates the expression of the high mobility group protein HMG-I(Y) gene in mouse 10T1/2 cells.

Authors:  T Kinoshita; H Shirasawa; Y Shino; K Shimizu; H Moriya; B Simizu
Journal:  Virus Res       Date:  1996-06       Impact factor: 3.303

9.  The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis.

Authors:  S Battista; V Fidanza; M Fedele; A J Klein-Szanto; E Outwater; H Brunner; M Santoro; C M Croce; A Fusco
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

10.  Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.

Authors:  G Chiappetta; G Tallini; M C De Biasio; G Manfioletti; F J Martinez-Tello; F Pentimalli; F de Nigris; A Mastro; G Botti; M Fedele; N Berger; M Santoro; V Giancotti; A Fusco
Journal:  Cancer Res       Date:  1998-09-15       Impact factor: 12.701

View more
  7 in total

1.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

2.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

3.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

4.  MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells.

Authors:  Karthik Subramanian Chandrasekaran; Anusha Sathyanarayanan; Devarajan Karunagaran
Journal:  Br J Cancer       Date:  2016-08-18       Impact factor: 7.640

5.  HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.

Authors:  Fangfang Fu; Tian Wang; Zhangying Wu; Yourong Feng; Wenwen Wang; Su Zhou; Xiangyi Ma; Shixuan Wang
Journal:  Cell Death Dis       Date:  2018-05-22       Impact factor: 8.469

Review 6.  HMGA1 in cancer: Cancer classification by location.

Authors:  Yuhong Wang; Lin Hu; Yushuang Zheng; Lingchuan Guo
Journal:  J Cell Mol Med       Date:  2019-01-07       Impact factor: 5.310

7.  Galectin-3 impairment of MYCN-dependent apoptosis-sensitive phenotype is antagonized by nutlin-3 in neuroblastoma cells.

Authors:  Veronica Veschi; Marialaura Petroni; Beatrice Cardinali; Carlo Dominici; Isabella Screpanti; Luigi Frati; Armando Bartolazzi; Alberto Gulino; Giuseppe Giannini
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.